Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Archives of Neurology

• Publication date

  1998-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.55.7.964PMID 9678314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence and risk of dementia. The Rotterdam Study.

  1998cited by this paper
• Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.

  1997cited by this paper
• The absence of an apolipoprotein ϵ4 allele is associated with a more aggressive form of Alzheimer's disease

  1997cited by this paper
• Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation.

  1997cited by this paper
• Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons.

  1997cited by this paper
• Impact of Sample Selection on APOE ∈4 Allele Frequency: A Comparison of Two Alzheimer's Disease Samples

  1996cited by this paper
• Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.

  1996cited by this paper
• Familial and Population‐Based Studies of Apolipoprotein E and Alzheimer's Disease a

  1996cited by this paper
• Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women.

  1996influential reference
• Impact of sample selection on APOE epsilon 4 allele frequency: a comparison of two Alzheimer's disease samples.

  1996cited by this paper
• Apolipoprotein E genotyping in Alzheimer's disease

  1996cited by this paper
• Apolipoprotein E element 4 association with dementia in a population-based study

  1996cited by this paper
• Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample.

  1996cited by this paper
• Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.

  1995cited by this paper
• Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study

  1995cited by this paper
• Apolipoprotein E allele ∈4, dementia, and cognitive decline in a population sample

  1995cited by this paper
• Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease.

  1995cited by this paper
• Apolipoprotein E ε4 allele and the lifetime risk of Alzheimer's disease : what physicians know, and what they should know

  1995influential reference
• The apolipoprotein E ε2 allele is associated with an increased risk of early‐onset alzheimer's disease and a reduced survival

  1995cited by this paper
• The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival.

  1995cited by this paper
• Clinical-neuropathological correlations in Alzheimer's disease and related dementias.

  1994cited by this paper
• Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

  1994cited by this paper
• Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease.

  1994cited by this paper
• Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease

  1994cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Vascular dementia

  1993cited by this paper
• Apolipoprotein E genotyping by one-stage PCR.

  1991cited by this paper
• Determinants of disease and disability in the elderly: The Rotterdam elderly study

  1991cited by this paper
• The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances.

  1991cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised

  1988cited by this paper
• Measures of disease frequency

  1986cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• The role of Apolipoprotein E4 on cognitive impairment in Parkinson’s disease and Parkinsonisms

  2025cites this paper
• Association of road traffic noise exposure with dementia or cognitive impairment - a systematic review of longitudinal cohort studies

  2025cites this paper
• The Potential for Neuromodulation in the Treatment of Alzheimer’s Disease: A Review of Clinical Trials

  2025cites this paper
• Association of Early Life Risk Factors and APOE ε4 With Incident Dementia: Evidence From 14 Years of U.S. Data

  2025cites this paper
• Cortical asymmetry in autosomal dominant Alzheimer’s disease progression

  2025cites this paper
• Feasibility and acceptability of remote APOE-genotyping among research volunteers of an online recruitment registry (The Dutch Brain Research Registry)

  2025cites this paper
• Aging, Rather than Genotype, Is the Principal Contributor to Differential Gene Expression Within Targeted Replacement APOE2, APOE3, and APOE4 Mouse Brain

  2025cites this paper
• Associations of perceived neighborhood factors and Alzheimer’s disease polygenic score with cognition: Evidence from the Health and Retirement Study

  2025cites this paper
• Identification of disease-specific bio-markers through network-based analysis of gene co-expression: A case study on Alzheimer's disease

  2024cites this paper
• Microglia Signatures: A Cause or Consequence of Microglia-Related Brain Disorders?

  2024cites this paper
• A 12-year comparison of patients with Alzheimer's dementia with their informants in eight Asian countries.

  2024cites this paper
• Impacts of APOE-ε4 and exercise training on brain microvascular endothelial cell barrier function and metabolism

  2024cites this paper
• Genetics and precision health: the ecological fallacy and artificial intelligence solutions

  2023cites this paper
• A data-driven study of Alzheimer's disease related amyloid and tau pathology progression

  2023cites this paper
• Direct to Consumer Biomarker Testing for Alzheimer Disease-Are We Ready for the Insurance Consequences?

  2023cites this paper
• A 12-Year Comparison of Alzheimer’s Dementia Patients With Their Informants in Taiwan

  2023cites this paper
• Ultra-Early Screening of Cognitive Decline Due to Alzheimer’s Pathology

  2023cites this paper
• What does heritability of Alzheimer’s disease represent?

  2023cites this paper
• The Impact of Apolipoprotein E (APOE) Epigenetics on Aging and Sporadic Alzheimer’s Disease

  2023cites this paper
• Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study

  2023cites this paper
• Apolipoprotein E (APOE) genotype, dementia, and memory performance among Caribbean Hispanic versus US populations

  2022cites this paper
• Young Adults with a Parent with Dementia Show Early Abnormalities in Brain Activity and Brain Volume in the Hippocampus: A Matched Case-Control Study

  2022cites this paper
• Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers.

  2022cites this paper
• Links between inflammation and immune functioning with cognitive status among older Americans in the Health and Retirement Study

  2022cites this paper
• A common haplotype lowers SPI1 expression in myeloid cells and delays age at onset for Alzheimer’s disease of Alzheimer's Alzheimer's Disease Neuroimaging Initiative

  2022cites this paper
• Polimorfismos del gen de la apolipoproteína E en adultos mayores de 60 años con disminución de la memoria cognitiva y enfermedad de Alzheimer en diferentes poblaciones venezolanas

  2022cites this paper
• My Healthy Brain: Rationale and Case Report of a Virtual Group Lifestyle Program Targeting Modifiable Risk Factors for Dementia

  2022cites this paper
• Apathy and APOE in mild behavioral impairment, and risk for incident dementia

  2022cites this paper
• Social network and the risk for developing mild cognitive impairment and dementia among older adults

  2022cites this paper
• Healthcare services relaxing natural selection may contribute to increase of dementia incidence

  2022cites this paper
• Incidence and Cognitive Decline of Alzheimer’s Disease and Other Dementia by Apolipoprotein ε4 Allele Presence: A Community-Based Cohort Study in Korean Elderly

  2022cites this paper
• What does heritability of Alzheimer’s disease represent?

  2022cites this paper
• The National Institute on Aging Late‐Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery

  2022cites this paper
• COVID-19 in structure of risk factors for cognitive impairment, methods of correction

  2022cites this paper
• A meta-analysis of Alzheimer's disease's relationship with human ApoE gene variants.

  2021influential citation
• Estimating the familial risk of psychiatric illnesses: A review of family history scores.

  2021cites this paper
• Genome-Wide Meta-Analysis of Late-Onset Alzheimer's Disease Using Rare Variant Imputation in 324,809 Subjects Identifies Novel Rare Variant Locus NCK2: The International Genomics of Alzheimer's Project (IGAP)

  2021cites this paper
• Advanced Healthcare Services Leading to Relax Natural Selection May Have Been Contributing to Global and Regional Increase of Dementia Incidence

  2021cites this paper
• The probabilistic model of Alzheimer disease: the amyloid hypothesis revised

  2021cites this paper
• The National Institute on Aging Late Onset Alzheimer's Disease Family Based Study: A Critical Component of the International Effort to Understand Alzheimer's Disease

  2021cites this paper
• Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer’s Disease Spectrum

  2021cites this paper
• Advances in Genetic and Molecular Understanding of Alzheimer’s Disease

  2021cites this paper
• Cumulative Genetic Risk and APOE ε4 Are Independently Associated With Dementia Status in a Multiethnic, Population-Based Cohort

  2021cites this paper
• Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia

  2021cites this paper
• Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6

  2021cites this paper
• A non-APOE Polygenic score for Alzheimer’s disease and APOE-ε4 have independent associations with dementia in the Health and Retirement Study

  2020cites this paper
• The MUC6/AP2A2 Locus and Its Relevance to Alzheimer’s Disease: A Review

  2020cites this paper
• Physical Activity as Moderator of the Association Between APOE and Cognitive Decline in Older Adults: Results from Three Longitudinal Cohort Studies

  2020cites this paper
• Risk and protective factors of dementia among adults with post-traumatic stress disorder: a systematic review protocol

  2020cites this paper
• Are cytochrome P4502D6 and apolipoprotein E genotypes associated with long‐term cognitive and functional changes in patients treated with donepezil?

  2020cites this paper
• Trajectories of Cognitive and Motor Function Between Ages 45 and 90 Years: A Population-Based Study

  2020cites this paper
• The association of depression with subsequent dementia diagnosis: A Swedish nationwide cohort study from 1964 to 2016

  2020cites this paper
• Blood–Brain Barrier Degradation and the Implication of SPARC Protein as a Potential Therapeutic Target for Alzheimer’s Disease

  2020cites this paper
• CDH6 and HAGH protein levels in plasma associate with Alzheimer’s disease in APOE ε4 carriers

  2020cites this paper
• Sensorimotor Inhibition and Mobility in Genetic Subgroups of Parkinson's Disease

  2020cites this paper
• Sex difference in Alzheimer's disease: An updated, balanced and emerging perspective on differing vulnerabilities.

  2020cites this paper
• Higher Plasma Amyloid-β Levels Are Associated with a Higher Risk of Cancer: A Population-Based Prospective Cohort Study

  2020influential citation
• Narrative video scene description task discriminates between levels of cognitive impairment in Alzheimer's disease.

  2020cites this paper
• Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease

  2020cites this paper
• Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs.

  2019cites this paper
• Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach

  2019cites this paper
• Clinical aspects of Alzheimer's disease.

  2019cites this paper
• Telomere Length and the Risk of Alzheimer’s Disease: The Rotterdam Study

  2019cites this paper
• Balance between innate versus adaptive immune system and the risk of dementia: a population-based cohort study

  2019cites this paper
• Public Willingness to Undergo Presymptomatic Genetic Testing for Alzheimer's Disease

  2019cites this paper
• A Review on the Trajectory of Attentional Mechanisms in Aging and the Alzheimer’s Disease Continuum through the Attention Network Test

  2019cites this paper
• (2017). Using induced pluripotent stem cells to explore genetic and epigenetic variation associated with Alzheimer's disease.

  2019cites this paper
• Effect of ApoE4 Genotype on the Association Between Metabolic Phenotype and Subclinical Atherosclerosis in Postmenopausal Women.

  2019cites this paper
• APOE genotypes in Lebanon: distribution and association with hypercholesterolemia and Alzheimer's disease.

  2019cites this paper
• Microglia as Dynamic Cellular Mediators of Brain Function.

  2019cites this paper
• A common haplotype lowers SPI1 expression in myeloid cells and delays age at onset for Alzheimer’s disease

  2018cites this paper
• Psoriasis is not associated with cognition, brain imaging markers and risk of dementia: the Rotterdam Study.

  2018cites this paper
• Towards the validation of a druggable amyloid-beta oligomer as a target for Alzheimer´s disease = Cap a la validació d’un oligomer de beta-amiloide com a diana en la malaltia d’Alzheimer

  2018cites this paper
• Microglial phagocytosis of amyloid plaques in an ex vivo model of Alzheimer's Disease

  2018cites this paper
• Epigenetic characterisation of ANK1, a novel gene implicated in Alzheimer’s disease (AD)

  2018cites this paper
• Neurotoxicity of Aluminum

  2018influential citation
• Cross Talk Between Aluminum and Genetic Susceptibility and Epigenetic Modification in Alzheimer's Disease.

  2018cites this paper
• Targeting Insulin for Alzheimer’s Disease: Mechanisms, Status and Potential Directions

  2018cites this paper
• Microglial signatures and their role in health and disease

  2018cites this paper
• Variants regulating ZBTB4 are associated with age‐at‐onset of Alzheimer's disease

  2018cites this paper
• APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts

  2017cites this paper
• Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis

  2017cites this paper
• The Psychosocial Effects of Next Generation Sequence Panels for Predictive Testing of Hereditary Dementias

  2017cites this paper
• Genetics of Alzheimer's disease: an update

  2017cites this paper
• A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease

  2017cites this paper
• Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer’s Disease

  2017cites this paper
• Energy and the Alzheimer brain

  2017cites this paper
• Polygenic risk scores in familial Alzheimer disease

  2017cites this paper
• Using induced pluripotent stem cells to explore genetic and epigenetic variation associated with Alzheimer's disease.

  2017cites this paper
• Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer's disease.

  2017cites this paper
• Modulation of APOE and SORL1 genes on hippocampal functional connectivity in healthy young adults

  2017cites this paper
• Clinical Aspects of Alzheimer's Disease.

  2017cites this paper
• Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases

  2017cites this paper
• Association of Apolipoprotein E , Methylenetetrahydrofolate Genotypes , Lipids levels and Alzheimer Disease in an Algerian Population

  2017cites this paper
• Integrating Omic Technologies in Alzheimer's Disease.

  2017cites this paper
• Elucidating novel dysfunctional pathways in Alzheimer's disease by integrating loci identified in genetic and epigenetic studies

  2016cites this paper
• Genomics of Alzheimer's disease: Value of high-throughput genomic technologies to dissect its etiology.

  2016cites this paper
• Association between DCHS2 gene and mild cognitive impairment and Alzheimer's disease in an elderly Brazilian sample

  2016cites this paper
• Dementias.

  2016cites this paper
• Emerging Link between Alzheimer's Disease and Homeostatic Synaptic Plasticity

  2016cites this paper